Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2017

Feb 1, 2017

30291_dirs_2017-02-01_bfe0bb47-0632-4fdd-beb5-80189a095a23.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bioverativ Inc. (BIVV)
CIK: 0001681689
Period of Report: 2017-02-01

Reporting Person: BIOGEN INC. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-01 Common Stock J 107975968 Disposed 0 Direct

Footnotes

F1: Biogen Inc. distributed the shares to its shareholders on a pro rata basis in connection with the separation of the Issuer from Biogen Inc. on February 1, 2017.

F2: On January 31, 2017, the 1,000 shares of common stock of the Issuer, issued and outstanding as of such date, were reclassified and subdivided into 107,975,968 shares resulting in the reporting person's ownership of a total of 107,975,968 shares of common stock.